Thursday, 2 December 2021

Australia's most trusted
source of pharma news

Thursday, 02 December 2021

PBS win ends wait for rare drug

Posted 22 November 2021 AM

In a win for Australians with the rare and potentially deadly condition, hereditary angioedema, Health Minister Greg Hunt has awarded Takeda's Takhzyro a PBS berth from December 1.

It's been a long haul for Takhzyro which first went before PBAC in July 2019. It was not recommended at that meeting and a second submission a year later in July 2020 was deferred. In a case of third time lucky, the therapy was finally ticked after PBAC's July meeting this year.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.